346 related articles for article (PubMed ID: 16047946)
1. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Szollosi Z; Nemeth T; Egervari K; Nemes Z
Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and immunoelectron microscopic characterization of major constituent cells in malignant fibrous histiocytoma using human cell lines and their transplanted tumors in immunodeficient mice.
Takeya M; Yamashiro S; Yoshimura T; Takahashi K
Lab Invest; 1995 Jun; 72(6):679-88. PubMed ID: 7783426
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tumour cells in malignant fibrous histiocytomas and other soft tissue tumours in comparison with malignant histiocytes. I. Immunohistochemical study on paraffin sections.
Roholl PJ; Kleyne J; Elbers H; Van der Vegt MC; Albus-Lutter C; Van Unnik JA
J Pathol; 1985 Oct; 147(2):87-95. PubMed ID: 2999365
[TBL] [Abstract][Full Text] [Related]
4. Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study.
Nemes Z; Thomázy V
Hum Pathol; 1988 Jul; 19(7):822-9. PubMed ID: 2900209
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor cells in malignant fibrous histiocytomas and other soft-tissue tumors, in comparison with malignant histiocytes. II. Immunoperoxidase study on cryostat sections.
Roholl PJ; Kleyne J; Van Unnik JA
Am J Pathol; 1985 Nov; 121(2):269-74. PubMed ID: 2414996
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a fibrous histiocytoma cell line (NMSG 10) derived from a malignant fibrous histiocytoma.
Yokota T; Ishizaki R; Ohishi H; Ohami H
Pathol Res Pract; 1995 Dec; 191(12):1231-8. PubMed ID: 8927571
[TBL] [Abstract][Full Text] [Related]
8. Malignant fibrous histiocytoma. History, histology, histogenesis.
Meister P
Pathol Res Pract; 1988 Feb; 183(1):1-7. PubMed ID: 2834705
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous atypical fibrous histiocytoma.
Garrido-Ruiz MC; Ramos P; Enguita AB; Rodriguez Peralto JL
Am J Dermatopathol; 2009 Jul; 31(5):499-501. PubMed ID: 19542931
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration cytopathology of malignant fibrous histiocytoma.
Berardo MD; Powers CN; Wakely PE; Almeida MO; Frable WJ
Cancer; 1997 Aug; 81(4):228-37. PubMed ID: 9292738
[TBL] [Abstract][Full Text] [Related]
11. Expression of stem cell factor and lack of c-kit expression in malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Nakatani T; Marui T; Akisue T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
Anticancer Res; 2003; 23(5b):4305-8. PubMed ID: 14666642
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry of markers of histiomonocytic cells in malignant fibrous histiocytomas. A monoclonal antibody study.
Soini Y; Miettinen M
Pathol Res Pract; 1990 Dec; 186(6):759-67. PubMed ID: 1964732
[TBL] [Abstract][Full Text] [Related]
13. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
14. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
Binder SW; Said JW; Shintaku IP; Pinkus GS
Am J Clin Pathol; 1992 Jun; 97(6):759-63. PubMed ID: 1317667
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
16. An unusual soft tissue tumor with features of angiomatoid malignant fibrous histiocytoma composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets. CD34 and factor XIIIa in angiomatoid MFH.
Silverman JS; Lomvardias S
Pathol Res Pract; 1997; 193(1):51-8; discussion 59-60. PubMed ID: 9112273
[TBL] [Abstract][Full Text] [Related]
17. The rise and fall of malignant fibrous histiocytoma.
Erlandson RA; Antonescu CR
Ultrastruct Pathol; 2004; 28(5-6):283-9. PubMed ID: 15764577
[TBL] [Abstract][Full Text] [Related]
18. Fibronectin in relation to growth patterns of fibrohistiocytic tumours--an immunohistochemical study of benign and malignant fibrous histiocytomas.
Stiller D; Bahn H
Acta Histochem; 1987; 82(1):95-108. PubMed ID: 2827424
[TBL] [Abstract][Full Text] [Related]
19. [A clinico-pathologic study of primary malignant fibrous histiocytoma of bone].
Liu P; Li J; Shen L
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):146-9. PubMed ID: 9206052
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
